Showing results (1-10 of 188) with videos related to
Sort By:
Pageof 19
Molecular Diagnosis & Therapy|December 27, 2023
Personalizing Oncolytic Immunovirotherapy ApproachesGeorgios M Stergiopoulos, Ianko Iankov, Evanthia GalanisJournal of Immunological Methods|February 14, 2021
Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2Ianko Iankov, Kimberly Viker, Coleman Turgeon, et al.Current Treatment Options in Oncology|June 19, 2024
An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant GliomasGeorgios M Stergiopoulos, Susanna C Concilio, Evanthia GalanisHuman Gene Therapy|December 22, 2011
Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS)Mateusz Opyrchal, Cory Allen, Ianko Iankov, et al.Virus Research|December 17, 2025
Replication competent La Crosse virus pseudotyped VSV vector system as vaccine and serological diagnostic reagentIanko Iankov, Arun Ammayappan, Kimberly Viker, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2017
Interleukin-13 Displaying Retargeted Oncolytic Measles Virus Strains Have Significant Activity Against Gliomas With Improved SpecificityCory Allen, Georgia Paraskevakou, Ianko Iankov, et al.Molecular Therapy. Oncology|January 16, 2026
Repurposing the SSRI paroxetine increases lymphocyte mobilization and improves the efficacy of measles virus-based immunovirotherapyGeorgios M Stergiopoulos, Susanna C Concilio, Kim B Viker, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2008
Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificityCory Allen, Georgia Paraskevakou, Ianko Iankov, et al.International Journal of Oncology|March 27, 2012
Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cellsAlexey A Leontovich, Shuya Zhang, Cosima Quatraro, et al.Current Opinion in Molecular Therapeutics|March 9, 2002
Technology evaluation: Allovectin-7, VicalEvanthia GalanisPageof 19